SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-021521
Filing Date
2023-05-12
Accepted
2023-05-12 09:00:49
Documents
61
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q igms-20230331.htm   iXBRL 10-Q 2684227
2 EX-31.1 igms-ex31_1.htm EX-31.1 19091
3 EX-31.2 igms-ex31_2.htm EX-31.2 17431
4 EX-32.1 igms-ex32_1.htm EX-32.1 11352
5 EX-32.2 igms-ex32_2.htm EX-32.2 11332
  Complete submission text file 0000950170-23-021521.txt   8816356

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT igms-20230331_lab.xml EX-101.LAB 476120
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT igms-20230331_cal.xml EX-101.CAL 45336
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT igms-20230331_def.xml EX-101.DEF 223959
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT igms-20230331.xsd EX-101.SCH 57801
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT igms-20230331_pre.xml EX-101.PRE 349847
55 EXTRACTED XBRL INSTANCE DOCUMENT igms-20230331_htm.xml XML 1561159
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Filer) CIK: 0001496323 (see all company filings)

IRS No.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39045 | Film No.: 23913461
SIC: 2834 Pharmaceutical Preparations